Bhavnagri Veer 4
4 · Allogene Therapeutics, Inc. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Tax Payment
Common Stock
2023-03-14$5.67/sh−23,628$133,971→ 556,049 total
Footnotes (2)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Includes 2,000 shares of the Issuer's common stock acquired by the reporting person on March 15, 2023 pursuant to an employee stock purchase program.